Literature DB >> 7914991

Autoimmune syndrome induced by omeprazole.

K Sivakumar, M C Dalakas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914991     DOI: 10.1016/s0140-6736(94)92008-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?

Authors:  David W J Clark; Johanna Strandell
Journal:  Eur J Clin Pharmacol       Date:  2006-04-22       Impact factor: 2.953

2.  Esomeprazole-induced rhabdomyolysis in a patient with heart failure.

Authors:  Uwe Tröger; Ines Reiche; Marilene S Jepsen; Christof Huth; Stefanie M Bode-Böger
Journal:  Intensive Care Med       Date:  2010-03-13       Impact factor: 17.440

3.  Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database.

Authors:  Alice Capogrosso Sansone; Irma Convertino; Maria Teresa Galiulo; Stefano Salvadori; Stefania Pieroni; Tamara Knezevic; Stefania Mantarro; Alessandra Marino; Manfred Hauben; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

4.  Prescription medication use and antinuclear antibodies in the United States, 1999-2004.

Authors:  Gregg E Dinse; Christine G Parks; Helen C S Meier; Caroll A Co; Edward K L Chan; Todd A Jusko; James Yeh; Frederick W Miller
Journal:  J Autoimmun       Date:  2018-05-18       Impact factor: 7.094

5.  Polymyositis Presenting as Rhabdomyolysis After the Initiation of Omeprazole.

Authors:  Jonathan K Jakubowski; Rosemina Patel; Venkata Buddharaju
Journal:  Cureus       Date:  2020-05-14

6.  Rhabdomyolysis associated with single-dose intravenous esomeprazole administration: A case report.

Authors:  Dae-Hong Jeon; Yire Kim; Min Jeong Kim; Hyun Seop Cho; Eun Jin Bae; Se-Ho Chang; Dong Jun Park
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.